Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in Egypt to 2011

Published by: Datamonitor

Published: Jul. 31, 2008 - 189 Pages


Table of Contents


Chapter 1 EXECUTIVE SUMMARY
Summary Market Level - OTC Healthcare
Summary category level - Analgesics
Summary category level - Cough and Cold Preparations
Summary category level - Traditional Medicines
Summary category level - First Aid Kits
Summary category level - Indigestion Preparations
Summary category level - Vitamins and Minerals
Summary category level - Plasters & Bandages
Summary category level - Medicated Skin Products
Summary category level - Other OTC Healthcare Products
Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
What is this report about?
How to use this report
Market Definition
Chapter 3 MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
GlaxoSmithKline Plc
Pfizer Inc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
Value
Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
Product launches over time
Recent product launches
Chapter 17 EGYPT SOCIOECONOMIC PROFILE
Country Overview
Key Facts
Political Overview
Egypt Economic Overview
Chapter 18 EGYPT MACROECONOMIC PROFILE
Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
Chapter 20 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: Egypt OTC Healthcare value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 2: Egypt OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: Egypt OTC Healthcare company share, by value, 2005-2006 (%)
Figure 4: Egypt Analgesics value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 5: Egypt Analgesics category growth comparison, by value, 2001-2011
Figure 6: Egypt Analgesics company share, by value, 2005-2006 (%)
Figure 7: Egypt Cough and Cold Preparations value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 8: Egypt Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: Egypt Cough and Cold Preparations company share, by value, 2005-2006 (%)
Figure 10: Egypt Traditional Medicines value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 11: Egypt Traditional Medicines company share, by value, 2005-2006 (%)
Figure 12: Egypt First Aid Kits value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 13: Egypt First Aid Kits company share, by value, 2005-2006 (%)
Figure 14: Egypt Indigestion Preparations value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 15: Egypt Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 16: Egypt Indigestion Preparations company share, by value, 2005-2006 (%)
Figure 17: Egypt Vitamins and Minerals value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 18: Egypt Vitamins and Minerals category growth comparison, by value, 2001-2011
Figure 19: Egypt Vitamins and Minerals company share, by value, 2005-2006 (%)
Figure 20: Egypt Plasters & Bandages value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 21: Egypt Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 22: Egypt Plasters & Bandages company share, by value, 2005-2006 (%)
Figure 23: Egypt Medicated Skin Products value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 24: Egypt Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 25: Egypt Medicated Skin Products company share, by value, 2005-2006 (%)
Figure 26: Egypt Other OTC Healthcare Products value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 27: Egypt Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 28: Egypt Other OTC Healthcare Products company share, by value, 2005-2006 (%)
Figure 29: Egypt Topical OTC Medicines value & value forecast, 2001-2011 (EGP m, nominal prices)
Figure 30: Egypt Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 31: Egypt Topical OTC Medicines company share, by value, 2005-2006 (%)
Figure 32: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
Figure 33: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
Figure 34: Map of Egypt
Figure 35: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: Egypt OTC Healthcare value, 2001-2006 (EGP m, nominal prices)
Table 3: Egypt OTC Healthcare value forecast, 2006-2011 (EGP m, nominal prices)
Table 4: Egypt OTC Healthcare value, 2001-2006 (US$ m nominal prices)
Table 5: Egypt OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
Table 6: Egypt OTC Healthcare brand share, by value, 2005-2006 (%)
Table 7: Egypt OTC Healthcare value, by brand 2005-2006 (EGP m nominal prices)
Table 8: Egypt OTC Healthcare company share by value, 2005-2006 (%)
Table 9: Egypt OTC Healthcare value, by company, 2005-2006 (EGP m nominal prices)
Table 10: Egypt OTC Healthcare expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 11: Egypt OTC Healthcare forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 12: Egypt OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
Table 13: Egypt OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 14: GlaxoSmithKline Plc Key Facts
Table 15: Pfizer Inc Key Facts
Table 16: Egypt Analgesics value, 2001-2006 (EGP m, nominal prices)
Table 17: Egypt Analgesics value forecast, 2006-2011 (EGP m, nominal prices)
Table 18: Egypt Analgesics value, 2001-2006 (US$ m nominal prices)
Table 19: Egypt Analgesics value forecast, 2006-2011 (US$ m nominal prices)
Table 20: Egypt Analgesics brand share, by value, 2005-2006 (%)
Table 21: Egypt Analgesics value, by brand 2005-2006 (EGP m nominal prices)
Table 22: Egypt Analgesics company share by value, 2005-2006 (%)
Table 23: Egypt Analgesics value, by company, 2005-2006 (EGP m nominal prices)
Table 24: Egypt Analgesics expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 25: Egypt Analgesics forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 26: Egypt Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
Table 27: Egypt Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 28: Egypt Cough and Cold Preparations value, 2001-2006 (EGP m, nominal prices)
Table 29: Egypt Cough and Cold Preparations value forecast, 2006-2011 (EGP m, nominal prices)
Table 30: Egypt Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
Table 31: Egypt Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 32: Egypt Cough and Cold Preparations brand share, by value, 2005-2006 (%)
Table 33: Egypt Cough and Cold Preparations value, by brand 2005-2006 (EGP m nominal prices)
Table 34: Egypt Cough and Cold Preparations company share by value, 2005-2006 (%)
Table 35: Egypt Cough and Cold Preparations value, by company, 2005-2006 (EGP m nominal prices)
Table 36: Egypt Cough and Cold Preparations expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 37: Egypt Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 38: Egypt Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 39: Egypt Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 40: Egypt Traditional Medicines value, 2001-2006 (EGP m, nominal prices)
Table 41: Egypt Traditional Medicines value forecast, 2006-2011 (EGP m, nominal prices)
Table 42: Egypt Traditional Medicines value, 2001-2006 (US$ m nominal prices)
Table 43: Egypt Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 44: Egypt Traditional Medicines brand share, by value, 2005-2006 (%)
Table 45: Egypt Traditional Medicines value, by brand 2005-2006 (EGP m nominal prices)
Table 46: Egypt Traditional Medicines company share by value, 2005-2006 (%)
Table 47: Egypt Traditional Medicines value, by company, 2005-2006 (EGP m nominal prices)
Table 48: Egypt Traditional Medicines expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 49: Egypt Traditional Medicines forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 50: Egypt Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 51: Egypt Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 52: Egypt First Aid Kits value, 2001-2006 (EGP m, nominal prices)
Table 53: Egypt First Aid Kits value forecast, 2006-2011 (EGP m, nominal prices)
Table 54: Egypt First Aid Kits value, 2001-2006 (US$ m nominal prices)
Table 55: Egypt First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
Table 56: Egypt First Aid Kits brand share, by value, 2005-2006 (%)
Table 57: Egypt First Aid Kits value, by brand 2005-2006 (EGP m nominal prices)
Table 58: Egypt First Aid Kits company share by value, 2005-2006 (%)
Table 59: Egypt First Aid Kits value, by company, 2005-2006 (EGP m nominal prices)
Table 60: Egypt First Aid Kits expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 61: Egypt First Aid Kits forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 62: Egypt First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
Table 63: Egypt First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 64: Egypt Indigestion Preparations value, 2001-2006 (EGP m, nominal prices)
Table 65: Egypt Indigestion Preparations value forecast, 2006-2011 (EGP m, nominal prices)
Table 66: Egypt Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
Table 67: Egypt Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 68: Egypt Indigestion Preparations brand share, by value, 2005-2006 (%)
Table 69: Egypt Indigestion Preparations value, by brand 2005-2006 (EGP m nominal prices)
Table 70: Egypt Indigestion Preparations company share by value, 2005-2006 (%)
Table 71: Egypt Indigestion Preparations value, by company, 2005-2006 (EGP m nominal prices)
Table 72: Egypt Indigestion Preparations expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 73: Egypt Indigestion Preparations forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 74: Egypt Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 75: Egypt Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 76: Egypt Vitamins and Minerals value, 2001-2006 (EGP m, nominal prices)
Table 77: Egypt Vitamins and Minerals value forecast, 2006-2011 (EGP m, nominal prices)
Table 78: Egypt Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
Table 79: Egypt Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
Table 80: Egypt Vitamins and Minerals brand share, by value, 2005-2006 (%)
Table 81: Egypt Vitamins and Minerals value, by brand 2005-2006 (EGP m nominal prices)
Table 82: Egypt Vitamins and Minerals company share by value, 2005-2006 (%)
Table 83: Egypt Vitamins and Minerals value, by company, 2005-2006 (EGP m nominal prices)
Table 84: Egypt Vitamins and Minerals expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 85: Egypt Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 86: Egypt Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
Table 87: Egypt Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 88: Egypt Plasters & Bandages value, 2001-2006 (EGP m, nominal prices)
Table 89: Egypt Plasters & Bandages value forecast, 2006-2011 (EGP m, nominal prices)
Table 90: Egypt Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
Table 91: Egypt Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
Table 92: Egypt Plasters & Bandages brand share, by value, 2005-2006 (%)
Table 93: Egypt Plasters & Bandages value, by brand 2005-2006 (EGP m nominal prices)
Table 94: Egypt Plasters & Bandages company share by value, 2005-2006 (%)
Table 95: Egypt Plasters & Bandages value, by company, 2005-2006 (EGP m nominal prices)
Table 96: Egypt Plasters & Bandages expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 97: Egypt Plasters & Bandages forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 98: Egypt Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
Table 99: Egypt Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 100: Egypt Medicated Skin Products value, 2001-2006 (EGP m, nominal prices)
Table 101: Egypt Medicated Skin Products value forecast, 2006-2011 (EGP m, nominal prices)
Table 102: Egypt Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
Table 103: Egypt Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
Table 104: Egypt Medicated Skin Products brand share, by value, 2005-2006 (%)
Table 105: Egypt Medicated Skin Products value, by brand 2005-2006 (EGP m nominal prices)
Table 106: Egypt Medicated Skin Products company share by value, 2005-2006 (%)
Table 107: Egypt Medicated Skin Products value, by company, 2005-2006 (EGP m nominal prices)
Table 108: Egypt Medicated Skin Products expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 109: Egypt Medicated Skin Products forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 110: Egypt Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 111: Egypt Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 112: Egypt Other OTC Healthcare Products value, 2001-2006 (EGP m, nominal prices)
Table 113: Egypt Other OTC Healthcare Products value forecast, 2006-2011 (EGP m, nominal prices)
Table 114: Egypt Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
Table 115: Egypt Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
Table 116: Egypt Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
Table 117: Egypt Other OTC Healthcare Products value, by brand 2005-2006 (EGP m nominal prices)
Table 118: Egypt Other OTC Healthcare Products company share by value, 2005-2006 (%)
Table 119: Egypt Other OTC Healthcare Products value, by company, 2005-2006 (EGP m nominal prices)
Table 120: Egypt Other OTC Healthcare Products expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 121: Egypt Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 122: Egypt Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 123: Egypt Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 124: Egypt Topical OTC Medicines value, 2001-2006 (EGP m, nominal prices)
Table 125: Egypt Topical OTC Medicines value forecast, 2006-2011 (EGP m, nominal prices)
Table 126: Egypt Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
Table 127: Egypt Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 128: Egypt Topical OTC Medicines brand share, by value, 2005-2006 (%)
Table 129: Egypt Topical OTC Medicines value, by brand 2005-2006 (EGP m nominal prices)
Table 130: Egypt Topical OTC Medicines company share by value, 2005-2006 (%)
Table 131: Egypt Topical OTC Medicines value, by company, 2005-2006 (EGP m nominal prices)
Table 132: Egypt Topical OTC Medicines expenditure per capita, 2001-2006 (EGP, nominal prices)
Table 133: Egypt Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EGP, nominal prices)
Table 134: Egypt Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 135: Egypt Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 136: Global OTC Healthcare market value, 2006
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
Table 138: Leading players - Top 5 countries
Table 139: Egypt OTC Healthcare new product launches (reports) and SKUs, by company 2006
Table 140: Egypt OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
Table 141: Egypt OTC Healthcare new product launches (reports), by Package tags or Claims 2006
Table 142: Egypt OTC Healthcare new product launches (reports) - Recent 5 launches
Table 143: Egypt Key Facts
Table 144: Egypt population, by age group, 2000-2005 (millions)
Table 145: Egypt population forecast, by age group, 2005-2010 (millions)
Table 146: Egypt population, by gender, 2000-2005 (millions)
Table 147: Egypt population forecast, by gender, 2005-2010 (millions)
Table 148: Egypt real GDP, 2000-2005 (EGP bn, 2005 prices)
Table 149: Egypt real GDP forecast, 2005-2010 (EGP bn, 2005 prices)
Table 150: Egypt nominal GDP, 2000-2005 (EGP bn, nominal prices)
Table 151: Egypt real GDP, 2000-2005 (US$ bn, 2005 prices)
Table 152: Egypt real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
Table 153: Egypt consumer price index, 2000-2005 (2000=100)
Table 154: Egypt consumer price index, 2005-2010 (2000=100)
Table 155: Egypt exchange rate, 2000-2005

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Egypt. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment
  • Includes company and brand share data by categories
Highlights

The market for OTC Healthcare in Egypt increased between 2001-2006, growing at an average annual rate of 8.9%.

The leading company in the market in 2006 was GlaxoSmithKline Plc. The second-largest player was Pfizer Inc with Amoun Pharmaceuticals Co in third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008